g 25671 has been researched along with arachidonic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cerletti, C; de gaetano, G; del Maschio, A; Hatmi, M; Lefort, J; Vargaftig, BB | 1 |
| Cerletti, C; De Gaetano, G; Del Maschio, A; Livio, M | 1 |
| Lewis, GP; Smith, JR | 1 |
3 other study(ies) available for g 25671 and arachidonic acid
| Article | Year |
|---|---|
Effects of sulfinpyrazone and its metabolite G25671 on platelet activation and desensitization and on bronchoconstriction induced by the prostaglandin endoperoxide analog U46619.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Bronchi; Humans; Lung; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Sulfinpyrazone | 1987 |
Inhibition of human platelet cyclo-oxygenase activity by sulfinpyrazone and three of its metabolites.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Kinetics; Malondialdehyde; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Sulfinpyrazone; Thromboxane B2 | 1984 |
Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cheek; Cricetinae; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Male; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1984 |